Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry
Key imaging biomarkers associated with the progression were identified, which may offer prognostic information for providers. However, the study is limited by its predominantly Caucasian population and single-centre design, which may affect the generalisability of certain biomarkers.
Authors
- Alan G. Palestine (ORCID: https://orcid.org/0000-0001-6361-6767)
- Naresh Mandava (ORCID: https://orcid.org/0000-0003-3251-6469)
- Andrés Lisker-Cervantes (ORCID: https://orcid.org/0000-0001-6133-0116)
- Talisa E. de Carlo (ORCID: https://orcid.org/0000-0001-7289-1509)
- Jennifer L. Patnaik (ORCID: https://orcid.org/0000-0002-0375-0187)
- Vivian Rajeswaren (ORCID: https://orcid.org/0000-0001-7654-0984)
- Ramya Gnanaraj (ORCID: https://orcid.org/0000-0002-8559-7963)
- William S. Gange (ORCID: https://orcid.org/0000-0002-6632-250X)
- Anne M. Lynch (ORCID: https://orcid.org/0000-0001-6508-8136)
- Niranjan Manoharan (ORCID: https://orcid.org/0000-0001-5746-6854)
- Nihaal Mehta
Institutions
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- BMJ Open Ophthalmology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1136/bmjophth-2024-002112
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Research to Prevent Blindness
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- National Eye Institute
- National Center for Advancing Translational Sciences